395 related articles for article (PubMed ID: 25386057)
1. Hypoxia and fatty liver.
Suzuki T; Shinjo S; Arai T; Kanai M; Goda N
World J Gastroenterol; 2014 Nov; 20(41):15087-97. PubMed ID: 25386057
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.
Lefere S; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Devisscher L; Geerts A
Cell Mol Life Sci; 2016 Sep; 73(18):3419-31. PubMed ID: 27091156
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism.
Rankin EB; Rha J; Selak MA; Unger TL; Keith B; Liu Q; Haase VH
Mol Cell Biol; 2009 Aug; 29(16):4527-38. PubMed ID: 19528226
[TBL] [Abstract][Full Text] [Related]
5. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.
Türkay C; Ozol D; Kasapoğlu B; Kirbas I; Yıldırım Z; Yiğitoğlu R
Respir Care; 2012 Feb; 57(2):244-9. PubMed ID: 21762556
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis.
Qu A; Taylor M; Xue X; Matsubara T; Metzger D; Chambon P; Gonzalez FJ; Shah YM
Hepatology; 2011 Aug; 54(2):472-83. PubMed ID: 21538443
[TBL] [Abstract][Full Text] [Related]
7. Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms.
Musso G; Olivetti C; Cassader M; Gambino R
Semin Liver Dis; 2012 Feb; 32(1):49-64. PubMed ID: 22418888
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.
Nath B; Szabo G
Hepatology; 2012 Feb; 55(2):622-33. PubMed ID: 22120903
[TBL] [Abstract][Full Text] [Related]
9. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
[TBL] [Abstract][Full Text] [Related]
10. The role of hypoxia-inducible factor 1α in hepatic lipid metabolism.
Luo M; Li T; Sang H
J Mol Med (Berl); 2023 May; 101(5):487-500. PubMed ID: 36973503
[TBL] [Abstract][Full Text] [Related]
11. HIF in kidney disease and development.
Gunaratnam L; Bonventre JV
J Am Soc Nephrol; 2009 Sep; 20(9):1877-87. PubMed ID: 19118148
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice.
Nishiyama Y; Goda N; Kanai M; Niwa D; Osanai K; Yamamoto Y; Senoo-Matsuda N; Johnson RS; Miura S; Kabe Y; Suematsu M
J Hepatol; 2012 Feb; 56(2):441-7. PubMed ID: 21896344
[TBL] [Abstract][Full Text] [Related]
13. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice.
Li J; Grigoryev DN; Ye SQ; Thorne L; Schwartz AR; Smith PL; O'Donnell CP; Polotsky VY
J Appl Physiol (1985); 2005 Nov; 99(5):1643-8. PubMed ID: 16037401
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factors as molecular targets for liver diseases.
Ju C; Colgan SP; Eltzschig HK
J Mol Med (Berl); 2016 Jun; 94(6):613-27. PubMed ID: 27094811
[TBL] [Abstract][Full Text] [Related]
15. Perspective in chronic kidney disease: targeting hypoxia-inducible factor (HIF) as potential therapeutic approach.
Deshmukh AB; Patel JK; Prajapati AR; Shah S
Ren Fail; 2012; 34(4):521-32. PubMed ID: 22264075
[TBL] [Abstract][Full Text] [Related]
16. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
Huang LE
Cell Death Differ; 2008 Apr; 15(4):672-7. PubMed ID: 18188166
[TBL] [Abstract][Full Text] [Related]
17. EPAS1/HIF-2α is a driver of mammalian pexophagy.
Schönenberger MJ; Krek W; Kovacs WJ
Autophagy; 2015; 11(6):967-9. PubMed ID: 25997392
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
[TBL] [Abstract][Full Text] [Related]
19. The impact of obesity on liver histology.
Goodman ZD
Clin Liver Dis; 2014 Feb; 18(1):33-40. PubMed ID: 24274863
[TBL] [Abstract][Full Text] [Related]
20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
